BIOMAT Database Logo BIOMAT Database Logo

Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin. 2010

Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Welsh School of Pharmacy, Cardiff University, Cardiff CF10 3NB, UK.

Ribavirin is a nucleoside analogue with broad antiviral activity. Here we report the synthesis and biological evaluation of novel ribavirin ProTides designed to deliver the bioactive ribavirin monophosphate into cells. Some of the compounds display activity similar to the parent nucleoside against a range of viruses. Enzymatic, cell lysate and preliminary modeling studies have been performed to investigate the lack of enhancement of potency by the ProTides, and these indicate a failure at the final, amino acid cleavage step in the ProTide activation process, leading to inefficient release of the nucleoside monophosphate.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010756 Phosphoric Acids Inorganic derivatives of phosphoric acid (H3PO4). Note that organic derivatives of phosphoric acids are listed under ORGANOPHOSPHATES. Pyrophosphoric Acids,Acids, Phosphoric,Acids, Pyrophosphoric
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Synthesis of phosphoramidate prodrugs: ProTide approach.
June 2013, Current protocols in nucleic acid chemistry,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives.
November 2006, Journal of medicinal chemistry,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
August 2009, Bioorganic & medicinal chemistry letters,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
April 2007, Journal of medicinal chemistry,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
August 2009, Bioorganic & medicinal chemistry letters,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Application of Phosphoramidate ProTide Technology for the Synthesis of 5'-mRNA Cap Analogs Modified on the Exocyclic Amine Group.
February 2023, ChemMedChem,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
May 2005, Journal of medicinal chemistry,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
The application of the phosphoramidate ProTide approach confers micromolar potency against hepatitis C virus on inactive agent 4'-azidoinosine: kinase bypass on a dual base/sugar modified nucleoside.
June 2009, Bioorganic & medicinal chemistry letters,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
May 2009, Journal of virology,
Marco Derudas, and Andrea Brancale, and Lieve Naesens, and Johan Neyts, and Jan Balzarini, and Christopher McGuigan
Virogenomics: a novel approach to antiviral drug discovery.
June 2001, Drug discovery today,
Copied contents to your clipboard!